Novel functions and targets of miR-944 in human cervical cancer cells

Hong Xie1, Linkiat Lee, Patrick Scicluna

  • 1Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Cancer Center Karolinska, Karolinska University Hospital, Stockholm, Sweden.

Insights

MicroRNA-944 (miR-944) promotes cervical cancer cell growth and spread. This study identifies HECW2 and S100PBP as direct targets, offering new insights into cervical carcinogenesis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Specific microRNAs (miRNAs) show altered expression in cervical cancer, but their functions remain largely unknown.
  • miR-944 is significantly upregulated in cervical cancer tissues compared to normal tissues.
  • miR-944 is located within the intron of the tumor protein p63 (TP63) gene, often overexpressed in cervical carcinomas.

Purpose of the Study:

  • To investigate the biological functions of miR-944 in human cervical cancer cells.
  • To identify and validate direct molecular targets of miR-944.
  • To elucidate the role of miR-944 in cervical carcinogenesis.

Main Methods:

  • In vitro gain- and loss-of-function experiments were conducted on human cervical cancer cells.
  • Photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation followed by deep sequencing were used to identify miRNA targets.
  • Luciferase reporter assays and western blot analysis were employed for target validation.

Main Results:

  • miR-944 significantly promotes cell proliferation, migration, and invasion in cervical cancer cells.
  • miR-944 does not affect the apoptosis rate of cervical cancer cells.
  • HECT domain ligase W2 (HECW2) and S100P binding protein (S100PBP) were validated as direct targets of miR-944.

Conclusions:

  • miR-944 plays a crucial role in promoting key oncogenic behaviors in cervical cancer cells.
  • The identification of HECW2 and S100PBP as direct targets provides mechanistic insights into miR-944's function.
  • These findings contribute to understanding the role of miR-944 in cervical carcinogenesis and may suggest potential therapeutic targets.